Trade Nanostrg Te - NSTG CFD

Trading Conditions

• Spread: 0.05
• Long position overnight feeLong position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position-0.026179 %(-$1.05)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position0.003957 %($0.16)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-$1.05)

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  ($0.16)

Key Stats

• Prev. Close: 0.49
• Open: 0.48
• 1-Year Change: 9.09%
• Day's Range: 0.44 - 0.49

Nanostrg Te Company profile

About NanoString Technologies Inc

NanoString Technologies, Inc. develops, manufactures, and sells products of biological material. Its core technology includes chemistries that enable the labeling and counting of single molecules. The single-molecule chemistries enable the direct detection, identification, and quantification of individual target molecules in biological samples by attaching molecular reporters to each target molecule of interest. It uses its core technology to develop tools for scientific and clinical research. It offers two product platforms, including nCounter Analysis System, and its GeoMx Digital Spatial Profiler (GeoMx DSP) systems. The nCounter Analysis System is used to analyze the activity of genes in a single experiment and is also used by clinicians to analyze gene activity relevant for diagnostic applications. The GeoMx DSP is used to facilitate the analysis of selected regions of a biological sample to see how gene activity vary across those regions or in certain cell types.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, NanoString Technologies Inc revenues increased 24% to $145.1M. Net loss increased 5% to $115.3M. Revenues reflect Americas segment increase of 18% to $94.4M, Europe & Middle East segment increase of 31% to $35.2M. Higher net loss reflects Selling, general and administrative increase of 22% to $89.4M (expense), Stock-based Compensation in SGA increase of 56% to $21.3M (expense).

Equity composition

Common Stock $0.0001 Par, 06/13, Shares auth 150M, 14,594,745 shares issd, Insiders Own approx. 63%